Il-Yang Pharm Co. Ltd.

Neurology

Clinical research activity is centered on Parkinson’s disease, with attention to the management of motor and non-motor symptoms associated with neurodegenerative disease.

  • Parkinson’s disease treatment
  • Neurological disorder therapeutics
  • Movement disorder care

The sponsor’s trial portfolio reflects interest in therapies intended to address disease-related neurological impairment and clinical tolerability in central nervous system disorders.

Want to learn more about this study or check if you can participate? Contact us.

Matched clinical trials

  • Study of Radotinib safety and effectiveness compared to placebo in people with Parkinson’s disease

    Not recruiting

    2 1
    Investigated diseases:
    Investigated drugs:
    France